Ronald McCaughan
Director Ejecutivo en Noninvasive Medical Technologies, Inc. .
Perfil
Ronald McCaughan is currently the Chairman & Chief Executive Officer at Noninvasive Medical Technologies, Inc.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Noninvasive Medical Technologies, Inc.
 Noninvasive Medical Technologies, Inc. Medical SpecialtiesHealth Technology Noninvasive Medical Technologies, Inc. manufactures medical devices. Its products include IQ2, an impedance cardiograph device that uses thoracic electrical bio impedance to monitor hemo dynamics, including the blood flow, cardiac output, cardiac index, stroke volume and heart rate, ZOE Fluid Status Monitor, NcIQ Casualty Management System and ETag. The company was founded in 2003 and is headquartered in Las Vegas, NV. inf% | 09/02/2007 | 1 190 476 ( inf% ) | - $ | Hoy |
Cargos activos de Ronald McCaughan
| Empresas | Cargo | Inicio |
|---|---|---|
Noninvasive Medical Technologies, Inc.
Noninvasive Medical Technologies, Inc. Medical SpecialtiesHealth Technology Noninvasive Medical Technologies, Inc. manufactures medical devices. Its products include IQ2, an impedance cardiograph device that uses thoracic electrical bio impedance to monitor hemo dynamics, including the blood flow, cardiac output, cardiac index, stroke volume and heart rate, ZOE Fluid Status Monitor, NcIQ Casualty Management System and ETag. The company was founded in 2003 and is headquartered in Las Vegas, NV. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Noninvasive Medical Technologies, Inc.
Noninvasive Medical Technologies, Inc. Medical SpecialtiesHealth Technology Noninvasive Medical Technologies, Inc. manufactures medical devices. Its products include IQ2, an impedance cardiograph device that uses thoracic electrical bio impedance to monitor hemo dynamics, including the blood flow, cardiac output, cardiac index, stroke volume and heart rate, ZOE Fluid Status Monitor, NcIQ Casualty Management System and ETag. The company was founded in 2003 and is headquartered in Las Vegas, NV. | Health Technology |
- Bolsa de valores
- Insiders
- Ronald McCaughan
